Glycan’s in Vaccine Development

Glycan’s are at the centre of many disorders and diseases igniting the possibility of exploiting them for therapeutic and diagnostic purposes. There are many biochemical pathways and diseases in which glycan’s are intricately involved. Determining the entire capacity and the promise that glycobiology holds, many pharma and biotech companies have already started allocating their R&D budget to it. Presently, with our drug arsenal fast depleting against drug resistant and mutant pathogens, glycobiology hold an untapped source of new candidate drugs.

  • Glycoconjugate vaccines
  • Glycoengineering of immunogens
  • Biomarkers in drug design
  • Biomarkers in drug design
  • Drug interaction in cellular networking
  • Biodefense vaccine mechanism

Related Conference of Glycan’s in Vaccine Development

October 30 - 31, 2017

3rd International Conference on Transcriptomics

Bangkok, Thailand
November 8-9, 2017

International Summit on Nanotechnology and Medical Robots

New Orleans, Louisiana, USA
November 13-14, 2017

9th International Conference on Bioinformatics

Paris, France
March 12-14, 2018

Glycobiology Biochem Conference 2018

Paris, France
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany

Glycan’s in Vaccine Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in